secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2025-05-27T23:59:59+00:00
Accession:  0001104659-25-052719
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed appoints Brandi Roberts as CFO effective June 2, 2025; inducement awards granted
--------------------------------------------------------------------------------

- Roberts previously CFO of Longboard Pharmaceuticals, led IPO and $2.6B Lundbeck acquisition.
- Base salary $495,000; eligible for annual cash bonus up to 40% of base salary.
- Inducement awards: option for 500,000 shares (4-year vest) and 125,000 PSUs (3-year vest, 0-200% payout).
- Roberts replaces Carrie Liao as principal financial and accounting officer effective June 2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/0001104659-25-052719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925052719/tm2516110d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-052719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer